TXMD - מכפיל מחיר לרווח לצמיחה TherapeuticsMD Corp

Geopolitical logistics disruptions are hindering component deliveries, which, coupled with the transition to a licensing royalty model, shapes the dynamics of the peg_co metric shown on this GURU.Markets chart for TherapeuticsMD, Inc. (TXMD), where the latest parameter stands at 0.00. This helps identify cost risks amplified by the total dependence of hormone drug production on third-party contractors.

Identifying fundamentally resilient assets requires aligning business valuation with growth dynamics. This metric is calculated by dividing the P/E ratio by the earnings growth rate to determine whether the current market price is fair. For TherapeuticsMD, Inc. (TXMD), high consumer loyalty to hormone therapies creates a predictable cash flow that should be reflected in expansion rates. A value below one indicates an undervaluation of growth potential. By analyzing the PEG ratio, an investor can uncover the company's hidden value.